即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS号 | 1103500-20-4 | 货号 | BCP33226 |
中文名 | LY2562175 | ||
英文名 | LY2562175 | ||
中文别名 | |||
英文别名 | LY 2562175; LY-2562175; | ||
SMILES | CN C=C(C2=C1C=C(C=C2)N3CCC(CC3)OCC4=C( | ||
化学名称 | |||
分子式 | C28H27Cl2N3O4 | 分子量 | 540.44 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | LY2562175 is a potent and selective FXR agonist in vitro and has robust lipid modulating properties, lowering LDL and triglycerides while raising HDL in preclinical species. The preclinical ADME properties of LY2562175 were consistent with enabling once daily dosing in humans, and it was ultimately advanced to the clinic for evaluation in humans. LY2562175 promotes transcriptional activation of human FXR in a cell-based cotransfection assay with an EC50 of 193 nM (geometric mean). |
Tags:LY2562175 供应商,LY2562175 购买,LY2562175 生产,LY2562175 批量,LY2562175 供应,LY2562175 订购,LY2562175 采购